Risk assessment and genetic counseling for hematologic malignancies—Practice resource of the National Society of Genetic Counselors-Reference-Cited by-同舟云学术

Risk assessment and genetic counseling for hematologic malignancies—Practice resource of the National Society of Genetic Counselors

Published:2024-08-27 Issue: Volume: Page:
ISSN:1059-7700
Container-title:Journal of Genetic Counseling
language:en
Short-container-title:Journal of Genetic Counseling

Author:

Stewart Brittany L.¹^ORCID,Helber Hannah²³,Bannon Sarah A.⁴,Deuitch Natalie T.⁵,Ferguson Meghan⁶,Fiala Elise⁷,Hamilton Kayla V.⁸,Malcolmson Janet⁹¹⁰,Pencheva Bojana¹¹¹²,Smith‐Simmer Kelcy¹³¹⁴^ORCID

Affiliation:

1. Cleveland Clinic Cleveland Ohio USA

2. Department of Pediatrics Baylor College of Medicine Houston Texas USA

3. Hematology and Cancer Center Texas Children's Hospital Houston Texas USA

4. National Institute of Allergy & Infectious Diseases, National Institutes of Health Bethesda Maryland USA

5. National Human Genome Research Institute, National Institutes of Health Bethesda Maryland USA

6. GeneDx Gaithersburg Maryland USA

7. Memorial Sloan Kettering Cancer Center New York New York USA

8. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center Boston Massachusetts USA

9. Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada

10. Department of Molecular Genetics University of Toronto Toronto Ontario Canada

11. Department of Pediatrics Emory University School of Medicine Atlanta Georgia USA

12. Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Atlanta Georgia USA

13. Academic Affairs University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

14. University of Wisconsin Carbone Cancer Center UW Health Madison Wisconsin USA

Abstract

AbstractHematologic malignancies (HMs) are a heterogeneous group of cancers impacting individuals of all ages that have been increasingly recognized in association with various germline predisposition syndromes. Given the myriad of malignancy subtypes, expanding differential diagnoses, and unique sample selection requirements, evaluation for hereditary predisposition to HM presents both challenges as well as exciting opportunities in the ever‐evolving field of genetic counseling. This practice resource has been developed as a foundational resource for genetic counseling approaches to hereditary HMs and aims to empower genetic counselors who encounter individuals and families with HMs in their practice.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgc4.1959

Reference200 articles.

1. Diagnostic utility of telomere length testing in a hospital-based setting

2. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up

3. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita